Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 6:14 pm Purchase | 2025-03-31 | 13G | BioNTech SE BNTX | Medine GmbH | 42,178,034 17.600% | 882,306 (+2.14%) | Filing History |
| 2024-11-13 5:00 pm Sale | 2024-09-30 | 13G | BioNTech SE BNTX | ATHOS KG | 102,489,101 42.800% | -1,560,044 (-1.50%) | Filing History |
| 2024-02-21 5:01 pm Purchase | 2024-02-13 | 13D | Autolus Therapeutics plc AUTL | BioNTech SE | 33,333,333 12.500% | 33,333,333 (New Position) | Filing History |
| 2024-02-14 07:26 am Sale | 2023-12-31 | 13G | BioNTech SE BNTX | Medine GmbH | 41,295,728 17.400% | -966,311 (-2.29%) | Filing History |
| 2024-02-07 5:03 pm Sale | 2023-12-31 | 13G | BioNTech SE BNTX | ATHOS KG | 104,049,145 43.800% | -1,563,998 (-1.48%) | Filing History |
| 2023-02-21 7:17 pm Purchase | 2022-12-31 | 13G | BioNTech SE BNTX | Medine GmbH | 42,262,039 17.400% | 756,186 (+1.82%) | Filing History |
| 2023-02-14 06:06 am Sale | 2022-12-31 | 13G | BioNTech SE BNTX | ATHOS KG | 105,613,143 43.500% | -502,908 (-0.47%) | Filing History |
| 2022-02-14 4:23 pm Sale | 2021-12-31 | 13G | BioNTech SE BNTX | Medine GmbH | 41,505,853 17.110% | -157,577 (-0.38%) | Filing History |
| 2022-02-11 5:01 pm Sale | 2021-12-31 | 13G | BioNTech SE BNTX | ATHOS KG | 106,116,051 43.800% | -10,520,254 (-9.02%) | Filing History |